Match tier Listed
Presence Formerly Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-08

Adetayo Odueke

Role not yet determined Is this you? Add your title

Also affiliated: University of Arkansas Medical Center (2025)

Formerly Arkansas Resident Physician, UAMS through 2026.

2 h-index 9 pubs 24 cited

  • Hypolipidemic Agents
  • Cardiovascular Diseases
  • Heart Disease Risk Factors
  • PCSK9 Inhibitors
  • Dicarboxylic Acids
  • Fatty Acids
  • Humans
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors

Biography and Research Information

OverviewAI-generated summary

Adetayo Odueke's research focuses on cardiovascular diseases, lipid-lowering therapies, and the cardiac implications of novel medical treatments. His work investigates mechanisms and therapeutic strategies for conditions such as coronary artery disease and cardiotoxicity associated with cancer therapies like CAR-T cell treatment. Odueke has published reviews on advances in non-statin lipid therapies and molecular insights into ischemia-reperfusion injury. He has also examined specific clinical scenarios, including bivalvular endocarditis in hemodialysis patients and acute kidney injury following CAR-T cell therapy.

His research explores the predictive factors for adverse cardiovascular events after CAR-T therapy and the significance of electrocardiogram changes in dobutamine stress echocardiography. Odueke collaborates with researchers from the University of Arkansas for Medical Sciences and the University of Arkansas at Fayetteville. His publication record includes work on mechanical circulatory support devices for cardiogenic shock and the surveillance of cardiotoxicity in targeted immunotherapy.

Metrics

  • h-index: 2
  • Publications: 9
  • Citations: 24

Positions

  • Resident Physician 2023–2026
    University of Arkansas for Medical Sciences Internal Medicine ORCID

Selected Publications

  • Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell therapy: Clinical Characteristics and Impact on Mortality (2026)
    Transplantation and Cellular Therapy DOI OpenAlex
  • TCT-262 Five-Year Mortality Comparison of Left Ventricular Unloading Devices for Individuals with Cardiogenic Shock on VA-ECMO (2025)
    Journal of the American College of Cardiology DOI OpenAlex
  • Advances in Non-statin Lipid Therapies: A Narrative Review of Evolving Strategies for Cardiovascular Risk Reduction (2025)
    American Journal of Cardiovascular Drugs 2 citations DOI OpenAlex
  • PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY (2025)
    Journal of the American College of Cardiology DOI OpenAlex
  • SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY (2025)
    Journal of the American College of Cardiology DOI OpenAlex
  • Molecular Insights into Ischemia–Reperfusion Injury in Coronary Artery Disease: Mechanisms and Therapeutic Implications: A Comprehensive Review (2025)
    Antioxidants 21 citations DOI OpenAlex
  • Abstract 4146588: Class 1C Antiarrhythmic Drugs are Safe in Patients with Arrhythmia-induced Cardiomyopathy Following Recovery of Left Ventricular Ejection Fraction (2024)
    Circulation DOI OpenAlex
  • A Rapidly Deteriorating Case of Bivalvular Endocarditis in a Hemodialysis Patient: A Case Report (2024)
    Cureus 1 citation DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

58 Collaborators 24 Institutions 6 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics